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PBS  Phosphate buffered saline 
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ε
-palmitoyl lysine methyl ester 
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Abstract 
 
Many strategies for treating diseases require the delivery of drugs into the cell cytoplasm 
following internalization within endosomal vesicles. Thus, compounds triggered by low pH to 
disrupt membranes and release endosomal contents into the cytosol are of particular interest. 
Here, we report novel cationic lysine-based surfactants (hydrochloride salts of N
ε
- and N
α
-acyl 
lysine methyl ester) that differ in the position of the positive charge and the length of the alkyl 
chain. Amino acid-based surfactants could be promising novel biomaterials in drug delivery 
systems, given their biocompatible properties and low cytotoxic potential. We examined their 
ability to disrupt the cell membrane in a range of pH values, concentrations and incubation 
times, using a standard hemolysis assay as a model of endosomal membranes. Furthermore, 
we addressed the mechanism of surfactant-mediated membrane destabilization, including the 
effects of each surfactant on erythrocyte morphology as a function of pH.  We found that only 
surfactants with the positive charge on the α-amino group of lysine showed pH-sensitive 
hemolytic activity and improved kinetics within the endosomal pH range, indicating that the 
positive charge position is critical for pH-responsive behavior. Moreover, our results showed 
that an increase in the alkyl chain length from 14 to 16 carbon atoms was associated with a 
lower ability to disrupt cell membranes. Knowledge on modulating surfactant-lipid bilayer 
interactions may help us to develop more efficient biocompatible amino acid-based drug 
delivery devices. 
 
Keywords: lysine-based surfactants; hemolysis; pH-sensitivity; membrane disruption; drug 
delivery 
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Introduction 
 
 Advances in strategies for treating a wide variety of diseases require the efficient 
delivery of the active compound into the cytosol or nucleus of target cells (Hu et al. 2007). 
Therapeutic agents, such as proteins, peptides, DNA and antitumor drugs, act at intracellular 
sites, thus their therapeutic efficacy depends on efficient intracellular trafficking (Plank et al. 
1998). Cells usually take up drug carriers via endocytosis that confines the internalized active 
compounds to vesicles (endosomes). Therefore, one of the challenges for efficient intracellular 
delivery of therapeutic compounds is to facilitate their release into the cytosol by destabilizing 
endosomal membranes under mildly acidic conditions (Chen et al. 2009; Stayton et al. 2000). 
This would manipulate or circumvent the non-productive trafficking from endosomes to 
lysosomes, thereby avoiding degradation at a pH as low as 4.6 (Mellman 1996). 
 Over the past two decades, considerable research has focused on delivery systems that 
specifically destabilize endosomal membranes following endocytic uptake (Christie and 
Grainger 2003). Carriers based on attenuated viruses have been studied extensively as pH-
dependent membrane-disruptive components in gene delivery systems to enhance transport 
from endosomes to the cytosol. However, clinical use of these carriers is limited by their 
antigenicity and toxicity (Gordon and Anderson 1994; McTaggart and Al-Rubeai 2002; Temin 
1990). Safety issues have prompted the development of synthetic peptides structurally derived 
from viruses to specifically disrupt endosomal membranes (Plank et al. 1998), but these 
peptides are also likely to be immunogenic in vivo (Sandhu et al. 1997). To overcome these 
limitations, a variety of non-viral delivery vectors have been studied, such as synthetic 
surfactants and polymers. Anionic lysine-based surfactants exhibit pH-responsive membrane-
lytic activity in the late endosomal pH range, thus showing promise for intracellular drug 
delivery systems (Nogueira et al. 2011). Polymerizable surfactants with tunable pH-sensitive 
amphiphilicity have been designed and tested as multifunctional delivery devices for systemic 
and targeted delivery of therapeutic siRNA (Wang et al. 2007, 2008, 2009). Moreover, 
cationic amino acid-based surfactants have been used to prepare biocompatible devices for the 
controlled encapsulation and release of DNA, where the surfactants form stable complexes 
with the oppositely charged DNA through electrostatic interactions (Morán et al. 2010). 
Cationic and anionic polymers with pH-sensitive activity, including derivatives of poly 
(acrylic acid) (Jones et al. 2003; Kusonwiriyawong et al. 2003; Kyriakides et al. 2002), 
methacrylic acid copolymers (Yessine et al. 2003), imidazole-containing polymers (Seo and 
Kim 2010) and pseudo-peptidic polymers (Chen et al. 2008, 2009), have also been developed 
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 4 
to promote endosomal release. Cationic polymers have been described to enhance membrane 
lysis at low pH via electrostatic interactions between protonated amines and the negatively 
charged membranes (Yessine et al. 2003).  
 Surfactants are one of the most widely applied excipients in the pharmaceutical 
industry due to their surface and interface activities (Paulsson and Edsman 2001). Those 
derived from amino acids usually present biocompatible properties and low cytotoxicity, and 
are therefore of great interest for pharmaceutical applications, especially in the field of novel 
non-viral drug delivery devices (Morán et al. 2010; Pérez et al. 2009). As surface properties 
(hydrophobicity and surface charge) have a major impact on cellular uptake of particulate 
drug delivery systems, the incorporation of charged surfactants into these carriers might 
improve targeting to specific cells (Schöler et al. 2001). Furthermore, surfactants with pH-
responsive membrane-disruptive activity may further destabilize endosomal compartments 
(Nogueira et al. 2011; Wang et al. 2007). The physicochemical and biological properties of 
cationic amino acid-based surfactants, as well as their synthesis, have been widely reported by 
our group (Colomer et al. 2011a; Lozano et al. 2011; Infante et al. 2010; Pérez et al. 2002, 
2009). Therefore, we selected biocompatible cationic surfactants from the amino acid lysine 
(hydrochloride salts of N
ε
- and N
α
-acyl lysine methyl ester) since they display lower toxicity 
potential and are classified as biodegradable (Pérez et al. 2009), and thus suitable for practical 
applications. 
 Here, we studied the membrane-destabilizing properties as a function of pH of three 
cationic lysine-based surfactants that differ in the position of the positive charge and the 
length of the alkyl chain. To evaluate their potential application in intracellular drug delivery 
systems, we examined the pH-dependent cell membrane-disruptive activity of these 
compounds using a standard hemolysis assay of rat erythrocytes as a model of endosomal 
membranes. The hemolysis dependence on the concentration and the kinetic properties of the 
surfactants at the endosomal pH range were also evaluated. Furthermore, we investigated the 
mechanisms involved in cell membrane disruption, including the effects of each surfactant on 
erythrocyte morphology at varying pH values. To gain insight into the structure-dependent 
interaction of these compounds with membrane bilayers, the influence of the charge position 
and alkyl chain length on hemolytic activity was also discussed.  
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Materials and Methods 
 
 Reagents 
 
 All solvents were reagent grade and were used without further purification. NaCl, 
Na2HPO4 and KH2PO4 were supplied by Merck (Darmstadt, Germany). Polyethylene glycol 
(PEG)-10,000, D-glucose and hexadecyl trimethyl ammonium bromide (HTAB) were from 
Sigma-Aldrich (St. Louis, MO, USA).  
 
Surfactants 
 
 Three biocompatible amino acid-based surfactants derived from N
ε 
or N
α
-acyl lysine 
methyl ester salts with one lysine as the cationic polar head (one cationic charge) and one 
alkyl chain were evaluated: N
ε
-myristoyl lysine methyl ester (MKM) with one alkyl chain of 
14 carbon atoms and one positive charge on the α-amino group of the lysine, Nε-palmitoyl 
lysine methyl ester (PKM) with one alkyl chain of 16 carbon atoms and one positive charge on 
the α-amino group of the lysine and Nα-myristoyl lysine methyl ester (MLM) with one alkyl 
chain of 14 carbon atoms and one positive charge on the ε-amino group of the lysine. MKM 
and PKM have a hydrophobic chain attached to the ε-amino group of the lysine, while MLM 
has the hydrophobic chain attached to the α-amino group of the lysine (Fig. 1). The 
commercial cationic surfactant hexadecyl trimethyl ammonium bromide ( HTAB) was used as 
the reference compound. These lysine-based surfactants were synthesized in our laboratory as 
previously described (Colomer et al. 2011a; Pérez et al. 2009) and made from natural fatty 
acid and amino acid organic building blocks. The chemical structure of these compounds was 
checked by nuclear magnetic resonance and their purity, higher than 99%, was confirmed by 
elemental analysis and high-performance liquid chromatography. In all cases, all building 
blocks were linked by amide bonds to form biodegradable molecules. See Table 1 for the 
physicochemical properties and analytical data. 
 
Preparation of erythrocyte suspensions 
 
 Rat blood was obtained from anesthetized animals by cardiac puncture and drawn into 
tubes containing EDTA. The procedure was approved by the institutional ethics committee on 
animal experimentation. Red blood cells were isolated by centrifugation at 3,000 rpm at 4 ºC 
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 6 
for 10 min and washed three times in an isotonic phosphate buffered saline (PBS) solution 
containing 123.3 mM NaCl, 22.2 mM Na2HPO4 and 5.6 mM KH2PO4 in distilled water (pH 
7.4; 300 mOsmol/l). The cell pellets were then suspended in PBS solution at a cell density of 8 
x 10
9
 cells/ml. 
 
Hemolysis assay 
 
 The membrane lytic activity of the surfactants was examined by hemolysis assay. PBS 
buffers in the pH range of 5.4 to 7.4 were prepared to be isosmotic inside the erythrocyte and 
cause negligible hemolysis. 25-μl aliquots of erythrocyte suspension were exposed to different 
surfactant concentrations based on preliminary studies (from 50 to 500 μg/ml for MKM and 
PKM, 10 to 60 μg/ml for MLM and 2.5 to 20 μg/ml for HTAB) and dissolved in PBS solution 
in a total volume of 1 ml. The samples were incubated at room temperature for 10 min. Two 
controls were prepared by resuspending erythrocyte suspension either in buffer alone 
(negative control) or in distilled water (positive control). The kinetic experiments were 
performed with concentrations associated with initial low hemolytic in the pH range of 
endosomal compartments (pH 6.5 and 5.4). The samples were incubated at room temperature 
under constant shaking for various periods up to 90 min. In all these hemolysis experiments, 
the samples were centrifuged at 10,000 rpm for 5 min at the end of each incubation time. 
Absorbance of the hemoglobin release in supernatants was measured at 540 nm using a 
Shimadzu UV-160A spectrophotometer (Shimadzu, Kyoto, Japan) and the percentages of 
hemolysis were determined by comparison with the positive control samples completely 
hemolyzed with distilled water. Concentration-response curves were obtained from the 
hemolysis results and the concentration inducing 50% hemolysis (HC50) was calculated.  
 
Osmotic protection experiments 
 
 To gain further insight into the mechanism of cell membrane disruption, the effect of 
osmolytes with different molecular weights on the membrane-disruptive activity of the 
surfactants was investigated. For this, PBS buffers at the pH range studied were prepared by 
adding D-glucose (180 Da) or polyethylene glycol (PEG)-10,000 (10 kDa) at a concentration 
of 10 mM, which is below the range at which these molecules alone induce hemolysis as a 
result of osmotic pressure (Murthy et al. 1999). Red blood cells were incubated with these 
buffers and exposed to a concentration of each surfactant that achieved significant hemolysis 
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 7 
in PBS buffer alone (500 μg/ml for MKM and PKM, and 60 μg/ml for MLM). Hemolysis was 
determined after incubating the cells for 10 min at room temperature, following the procedure 
described above. Controls with only the osmolytes were prepared to ensure that no hemolysis 
occured without the surfactants. 
  
 Erythrocyte count 
 
 Erythrocytes were counted in a Zeiss Axioskop optical microscope (Zeiss, Jena, 
Germany) using a Bürker counting chamber (Brand, Wertheim, Germany). The percentages of 
lysed erythrocytes at the required concentration of each surfactant (500 μg/ml for MKM and 
PKM, and 60 μg/ml for MLM) were determined relative to the total cell number in PBS buffer 
alone. The hemolysis experiment was performed following the procedure above at the same 
pH range and each sample was diluted four times for cell counts. 
 
Studies of rat erythrocyte morphology by scanning electron microscopy (SEM) 
 
 Interaction of the surfactants with the erythrocyte membrane in the pH range under 
study was determined by incubating intact cells with a sub-lytic concentration (10 μg/ml) of 
each surfactant. After a 10-minute incubation, samples were fixed by adding 1 ml of 2.5% 
glutaraldehyde in PBS solution and incubated at 4 ºC for 2 h. The samples were then 
centrifuged (1,500 rpm for 5 min), the supernatant was discarded, and 500 μl of 1.25% 
glutaraldehyde in PBS was added. Fixed samples were washed with PBS solution, postfixed 
with 1% osmium tetroxide, placed on a glass coverslip, dehydrated in an ascending series of 
ethyl alcohol (50 to 100%), air-dried by the critical point drying method using a CPD 7501 
apparatus (Polaron, Watford, UK), and finally mounted on an aluminium stub and gold-coated 
by an SEM coating system SC 510 (Fisons Instruments, East Grinstead, UK). Resulting 
specimens were examined under a Zeiss DSM 940A scanning electron microscope (Carl Zeiss 
SMT AG, Jena, Germany). 
 
Statistical analyses 
 
 Each hemolysis experiment was performed at least three times using three replicate 
samples for each surfactant concentration tested. Results are expressed as mean ± standard 
error of the mean (S.E.M.). Statistical analyses were performed using Student’s t test or one-
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 8 
way analysis of variance (ANOVA) to determine the differences between the datasets, 
followed by Bonferroni’s or Dunnett’s post-hoc tests for multiple comparisons using the 
SPSS
® 
 software (SPSS Inc., Chicago, IL, USA). P < 0.05, P < 0.01 and P < 0.005 were 
considered significant. Pearson’s correlation coefficients (r) between the HC50 and CMC 
values were also calculated by linear regression analysis. 
 
Results and Discussion 
 
Hemolysis assay 
 
 We studied the disruption of lipid bilayer membranes by cationic lysine-based 
surfactants. Erythrocytes are considered a simple cellular model and are therefore used as a 
convenient cell membrane system to study surfactant-membrane interactions (Sánchez et al. 
2007). We used a hemolysis assay with the erythrocyte membrane as a model of the 
endosomal membrane (Chen et al. 2009; Wang et al. 2007). Early endosomal compartments 
have a pH from 6.5 to 6.8, while the lumen of late endosomes has a lower pH, of about 5.5 
(Moore et al. 2008; Stayton et al. 2000). The lysosome has a pH as low as 4.6 to 5.0 (Mellman 
et al. 1996).  Therefore, we explored the membrane lytic activity of the class of compounds at 
the pH range of 5.4 to 7.4, mimicking the enviroment that the surfactant molecules are 
expected to encounter when incorporated into a drug delivery device translocating through the 
endocytic pathway. 
 The hemolytic activity of the surfactants was determined as a function of concentration 
at pH 5.4, 6.5 and 7.4. The concentration-dependent curves in Fig. 2 demonstrate that the 
membrane-disruptive activity of the surfactants was strongly influenced by concentration. At 
pH 7.4 (Fig. 2a), all the surfactants displayed almost a linear increase in hemolysis as a 
function of concentration. Moreover, the surfactants MKM and PKM were considerably less 
hemolytic than MLM and the commercial surfactant HTAB. MLM and HTAB (used as the 
reference compound) were nearly 9 and 30-fold more active in disrupting cell membranes at 
physiological conditions, respectively, as demonstrated by the HC50 values calculated from 
these curves (Table 2). 
 When the effect of concentration on hemolytic potency was evaluated at pH 6.5 (a very 
early stage of endosomal acidification), the surfactants showed different profiles (Fig. 2b). 
MKM and PKM displayed higher degrees of hemolysis than at physiological conditions (pH 
7.4) throughout the concentration range tested, and the differences in HC50 values were 
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 9 
significant (P < 0.05) (Table 2). MKM was much more potent in disrupting the plasma 
membrane at pH 6.5, showing 100% membrane lysis at 150 μg/ml, while only 36.91% 
hemolysis was observed at pH 7.4. PKM was 3.5-fold less efficient than MKM in disrupting 
plasma membrane on the basis of HC50, since almost complete disruption of erythrocyte 
membranes was only achieved gradually with an increasing concentration from 50 to 500 
μg/ml. In contrast, MLM was 2.5-fold less hemolytic at pH 6.5 than at pH 7.4, reaching 
maximum hemolysis of only 28.24% at 60 μg/ml while a maximum of 86.86% was reached at 
physiological conditions.  
 Finally, at pH 5.4 (a late stage of endosomal acidification) (Fig. 2c), the membrane 
lytic activity of MKM and PKM increased dramatically, reaching 100% hemolysis at low 
concentrations of 50 and 100 μg/ml, respectively. In contrast, MLM did not show increased 
activity at pH 5.4. Hemolysis was greater here than at pH 6.5 but still lower than in 
physiological conditions (Table 2). The commercial surfactant HTAB displayed the same 
concentration-dependent hemolytic activity in the endosomal and physiological pH range and 
differences in HC50 values were not significant (P > 0.05).  
 Despite the individual differences within the pH range tested, the hemolytic activity of 
all the compounds was strongly affected by concentration. In previous studies, we reported 
similar results for the membrane lytic activity of arginine-based gemini surfactants and 
anionic lysine-based surfactants (Mitjans et al. 2003; Nogueira et al. 2011). These results were 
as expected, since it has been widely reported that surfactants at high concentrations are 
hemolytic and membrane solubilization is often observed (Jones 1999; Maher and Singer 
1984). Here, the enhanced hemolysis with increasing surfactant concentration could also be 
due to increased ionic interactions between the negatively charged lipid membranes and 
positively charged amino groups of the surfactant molecule (Seo and Kim 2010). Furthermore, 
surfactant properties such as alkyl chain length, position of the cationic charge and head group 
hydrophobicity can significantly affect surfactant interaction with cell membranes (Colomer et 
al. 2011a). Our results here showed that the compounds with the positive charge in the α-
amino group (MKM and PKM) had lower disruptive potency at physiological pH and higher 
membrane lytic activity in the late endosomal pH range. Regarding the surfactants with the 
charge in the same position (MKM and PKM), concentration-dependent hemolytic activity 
decreased with increasing length of the hydrophobic tail. Likewise, several authors have 
reported similar results for the hemolysis of hydrogels of amino acid-based cationic 
amphiphiles (Roy and Das 2008) and of partially fluorinated pyridinium bromides (Vyas et al. 
2006). This behavior contrasts with the typically hemolytic activity described for cationic 
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surfactants, where longer alkyl chains are associated with higher membrane lytic activity 
(Rasia et al. 2007; Benavides et al. 2004). 
 It is worth mentioning that the HC50 values of MKM and MLM were below the critical 
micellar concentration (CMC) across the entire pH range studied here, indicating that the 
monomers are responsible for hemolytic activity and that micelles are not needed for 
surfactant-mediated cell lysis (Table 1). In contrast, PKM disrupted membranes at micellar 
concentrations in physiological conditions and in its monomer form in the pH range of 
endosomal compartments. The CMC was determined by conductivity measurements at 25 ºC 
of each surfactant aqueous solution at the adequate concentration range, following the 
procedure described by Colomer et al. (2011a). The CMC values of MKM and PKM were 
previously reported by our research group (Colomer et al. 2011b). We found no significant 
correlations (P > 0.05) between the CMC and the HC50 values at pH 7.4 (r = 0.7209) and 6.5 
(r = 0.8756). Several studies have been performed to demonstrate a correlation between 
hemolytic activity and the CMC of surfactants; however, there are no clear conclusions in the 
literature (Pérez et al. 2009; Preté et al. 2002; Spengler et al. 2011).  
 
pH-dependent hemolysis 
 
 To corroborate the pH-dependent hemolytic activity of MKM and PKM in contrast to 
MLM and HTAB, specific studies on the effects of pH were performed. At low concentrations 
(Fig. 3a), the surfactants showed low or negligible hemolytic activity at pH 7.4. When the pH 
was decreased to 6.5, MKM had increased membrane lytic activity and so did PKM but to a 
lesser extent, resulting in a maximum hemolysis of 37.51 and 15.23%, respectively. At pH 
5.4, the hemolytic activity of MKM and PKM increased considerably (P < 0.01), reaching 
maxima of 98.26 and 69.92%, respectively. The pK50 (pH at which 50% hemolysis is 
obtained) was also calculated for each surfactant from the pH-response curves showed in Fig. 
3a (Lee et al. 2010), with a value of approximately 6.2 for MKM, while the hemolysis 
response curve of PKM shifted toward lower pH and had an apparent pK50 of 5.6. These 
results support the early lytic activity of MKM at mildly acidic conditions (pH 6.5). MLM and 
HTAB showed no pH-sensitive activity throughout the endosomal pH range and thus, did not 
facilitate endosomal destabilization. 
 At concentrations near the HC50 values (Fig. 3b), MKM and PKM exhibited a 
concomitant rise in hemolytic activity at pH 7.4 and 6.5, reaching approximately 40 to 50% 
hemolysis at physiological conditions, while 71.5% and 100% hemolysis was recorded at pH 
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6.5 for PKM and MKM, respectively. At pH 5.4, MKM maintained the approximately 100% 
lysis observed at lower concentrations and PKM also reached total hemolysis. These 
observations demonstrated that surfactants at high concentrations do not retain the specific 
pH-responsive behavior, as significant hemolysis was also observed at physiological 
conditions. Surprisingly, higher concentrations of MLM displayed lower membrane-disruptive 
activity in acidic conditions than at physiological pH, while HTAB did not show any 
significant changes in its hemolytic potency throughout the pH range evaluated, confirming 
the inability to disrupt endosomal membranes. 
 Noteworthy was the significant rise in the hemolytic activity of MKM and PKM at pH 
5.4 and to a lesser extent at pH 6.5, while MLM demonstrated no pH-dependent responses. 
The difference between MKM and MLM lies in the polar group (position of the cationic 
charge), while MKM and PKM differ in the length of the hydrophobic tail. It has been 
suggested that protonation and pH-dependent activity may be governed by the overall pKa of 
the head group of the surfactants (Wang et al. 2007). Lysine is a dibasic amino acid consisting 
of two amino groups with different basicity since the α-amino group has a pKa = 8.9 and the 
ε-amino group a pKa = 10.5. However, to estimate the protonation state of the surfactant 
molecule in the pH range studied, we determined the apparent pKa values of the polar groups 
when they were included in the surfactant molecule. The pKa value of each compound was 
estimated by potentiometric titration, as described by Tabohashi et al. (2001). The titration 
was carried out at 25 ºC by adding increments of the NaOH solution to the surfactant solution 
with constant magnetic stirring, and the pKa value was obtained from the inflection point in 
the titration curve. The experimental pKa values obtained from pH measurements in aqueous 
medium were found to be considerably lower than those of the original lysine amino acid: 5.3 
and 4.5 for MKM and PKM (cationic charge in the α-amino group of the lysine), respectively 
(Colomer et al. 2011b), and 8.1 for MLM (cationic charge in the ε-amino group of the lysine). 
Given that the only difference between MKM and MLM is the position of the cationic charge, 
the pKa associated with the protonated amino group may be crucial for pH-sensitive 
membrane-disruptive activity. Consistent with these values, the lack of pH-responsive activity 
of MLM is related to the fact that no significant changes in the protonation state of the 
molecule took place in our experimental conditions, as the polar head should remain almost 
completely protonated throughout the studied pH range (which means an average charge of 
approximately 1).  In contrast, MKM and PKM have pKa values lower or in the order of the 
low pH range studied and therefore different protonation states can be achieved. The increased 
membrane-disruptive activity of these compounds in acidic conditions could be explained by a 
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modification in the hydrophobic/hydrophilic balance. At pH 5.4, the lysine in MKM is 
approximately 50% protonated (which means an average charge of 0.5), while PKM has a 
protonation state lower than 50% (average charge < 0.5) and hence, a lower ability to disrupt 
the lipid bilayer. This higher lytic activity of MKM is in accordance with the study reported 
by Chen et al. (2003), in which pH-sensitive acyloxyalkylimidazoles reached the maximum 
rate of hemolysis when about 50% of the molecule was protonated. The same reasoning is 
valid for the surfactant lytic activity at pH 6.5, in which MKM has a more protonated polar 
group and is thus more hemolytic than PKM (even though both compounds are less than 50% 
protonated).  More protonable amino groups add more charges to the polar head, which 
consequently increases membrane-lytic activity. At neutral pH, these compounds 
predominantly exist as unprotonated species, which explains the lower hemolysis achieved at 
physiological conditions. To summarize, surfactant membrane lytic activity changes with the 
pH as a consequence of the variation in the net charge at the studied pH range. Furthermore, 
concerning the surfactants that have the charge in the same position but differ in the alkyl 
chain length (MKM and PKM), our results showed that increasing the number of carbon 
atoms from 14 to 16 did not affect the pH-responsive behavior, but decreased membrane lytic 
activity in the endosomal pH range. In conclusion, the pH-sensitive membrane-disruptive 
activity of these surfactants can be fine-tuned mainly by varying the position of the cationic 
charge (by adjusting the pKa) and, to a lesser extent, by altering the length of the alkyl chain. 
 A strong correlation has been reported between hemolytic activity and endosomal 
disruption by membrane-disruptive agents (Plank et al. 1994). The cationic lysine-based 
surfactants with pH-sensitive properties were studied on the basis of the hypothesis that pH-
responsive membrane lytic activity in endosomes should facilitate membrane destabilization 
and allow surfactant-drug complexes to escape to the cytoplasm for efficient intracellular drug 
delivery. Numerous amphiphilic materials can mediate material transport across cell 
membranes, such as amphiphilic peptide sequences used by viruses (Janshoff et al. 1999) and 
amphiphilic lipids (Wasungu and Hoekstra 2006). However, virus peptides may have 
problems of immunogenicity and lipids may not selectively disrupt membranes at the 
endosomal pH. Our results demonstrated that MKM and PKM have specific pH-responsive 
membrane disruption at pH 5.4, the final most acidic endosomal pH, which may help to 
circumvent the non-productive trafficking of therapeutic compounds from endosomes to 
lysosomes, where degradation may occur. In summary, a useful intracellular drug delivery 
system should have low lytic activity at physiological pH and high destabilizing activity in the 
mildly acidic conditions found in the endosomes to elicit only selective endosomal membrane 
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disruption (Wang et al. 2007; Yessine et al. 2003). Low concentrations of PKM and MKM 
induced membrane lysis only at the endosomal pH range and there was no significant 
hemolysis at blood stream pH (7.4), supporting these surfactants as potential biocompatible 
materials in novel non-viral drug delivery systems. 
 
Kinetics of hemolytic activity 
 
Surfactant-mediated hemolysis was also determined as a function of time in the pH 
range characteristic of early and late endosomes (pH 6.5 and 5.4, respectively). The 
concentrations evaluated (25 μg/ml MKM, 50 μg/ml PKM, 20 μg/ml MLM and 5 μg/ml 
HTAB) were in the range of those that displayed specific pH-dependent activity and/or low 
degree of hemolysis after the initial 10 minutes of incubation. MKM and PKM showed 
improved kinetics of hemolytic activity at both stages of endosomal acidification. At pH 6.5 
(Fig. 4a), MKM caused 100% of hemolysis after 30 minutes of incubation, which 
corresponded to a membrane-disruptive activity approximately 17-fold higher than that 
observed after 10 minutes of incubation. PKM was less effective than MKM, as it showed a 
lag time of 30 minutes and achieved around 80% and 95% hemolysis only after 60 and 90 
minutes of incubation, respectively. The presence of a lag time implies the requirement of a 
minimum threshold amount of surfactant that has to accumulate in the lipid bilayer before 
hemoglobin leakage (Chen et al. 2003). At pH 5.4 (Fig. 4b), both compounds caused relatively 
weak hemolysis after 10 minutes of incubation, followed by a sharp increase to a maximum of 
about 80% (MKM) and 100% (PKM) after 90 minutes. The membrane lytic activity of MLM 
and the reference surfactant HTAB did not show any dependence on incubation time at the 
two pH values assessed, confirming their inability to disrupt endosomal membranes. 
 The significant hemolytic kinetics shown by MKM and PKM indicate that one or more 
previous steps are required before the erythrocyte membrane becomes permeable to 
hemoglobin. Among these steps, the most important could be the formation of pores or 
channels that lead to the efflux of low molecular weight solutes (see “Osmotic protection”). 
The molecules taken up by endocytosis are trafficked from early endosomes to lysosomes 
within several hours (Pack et al. 2005). Thus, timely permeabilization of the endosomal 
membrane is a prerequisite for cytosolic translocation of drugs in order to exert their 
pharmacological effect (Asokan and Cho 2005). Given the improved hemolytic kinetics and 
pH-responsive membrane activity of PKM and MKM, these compounds could disrupt 
endosomal membranes before fusion of the endocytic vesicles with lysosomes, thus avoiding 
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non-productive intracellular trafficking, a critical feature for potential intracellular drug 
delivery applications. 
 
Mechanism of cell membrane disruption 
 
Osmotic protection 
 
 To assess whether membrane lysis occurs through the colloid osmotic mechanism 
(after formation of transient defects or pores in the membrane due to surfactant treatment), an 
osmotic protection experiment was conducted in PBS solutions that contained molecules of 
varying sizes. The rationale behind this was that since sufficiently large molecules do not 
permeate through the cell membrane, their presence would counteract the osmotic pressure of 
the macromolecules inside the cell (especially hemoglobin), diminishing water penetration 
and consequently cell swelling (Murthy et al. 1999).  
 PEG-10,000 significantly (P < 0.05) inhibited surfactant-mediated hemolysis 
throughout the pH range studied, thereby indicating that defects such as pores or channels are 
formed in the erythrocyte membrane (Fig. 5). In the presence of PKM and MKM at pH 7.4, 
and MLM at pH 6.5, PEG-10,000 produced less pronounced inhibition of hemolysis, 
achieving maximum protection of 39.15, 43.26 and 35.96%, respectively. The highest 
protection degrees mediated by PEG-10,000 addition were 46.33, 58.19 and 75.83% for PKM 
and MKM at pH 6.5, and MLM at pH 7.4, respectively. Despite the significant degrees of 
protection against hemolysis after the addition of PEG-10,000, this osmolyte only partially 
avoided cell membrane disruption (generally by less than 50%) within the pH range studied. 
This means that the surfactants induced pores in the lipid bilayer that were smaller than the 
hydrodynamic radius of PEG-10,000 (hence, not permeable to this osmolyte, thereby 
decreasing hemolysis), as well as larger pores that were permeable to this protectant. The 
osmotic imbalance resulting from the diffusion of low molecular weight solutes out of the cell 
can not be balanced when these large pores are formed and consequently, cell lysis occurs. 
The overall observations of this experiment indicated that osmotic cell swelling was not the 
only mechanism involved in membrane lysis and other more complex mechanisms may also 
contribute. It is also feasible that cell membrane disruption could be due to partial 
solubilization of membrane lipids and proteins through micellization caused by extensive 
surfactant adsorption (Chernitsky and Senkovich 1998). Regardless of the partial inhibition of 
cell lysis and the complexity of the mechanisms involved, the significant protection against 
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hemolysis (P < 0.05) can be considered as evidence of the presence of an osmotic mechanism 
(Chernitsky and Senkovich 1998). Corroborating the osmotic mechanism, the low molecular 
weight D-glucose had no effect on the osmotic imbalance caused by the hemoglobin trapped in 
the erythrocyte cytoplasm (Fig. 5). Negligible or very small protection was observed and the 
degree of hemolysis did not differ significantly (P > 0.05) from that caused by the same 
surfactant concentration in PBS alone, except for PKM at pH 7.4 (P = 0.018) and MLM at pH 
5.4 (P = 0.01). For comparison, our previous studies on anionic lysine-based surfactants 
showed that PEG-10,000 almost completely protected against cell lysis at pH 7.4 and 6.5, 
while partial protection was only observed at pH 5.4 (Nogueira et al. 2011). 
 
Erythrocyte count 
 
 Erythrocyte counts were performed to study whether hemoglobin passes through the 
cell membrane or whether it is released into the extracellular medium after cell membrane 
rupture (Chen et al. 2009; Nogueira et al. 2011). The overall cell numbers declined 
significantly after 10 minutes of incubation with the hemolytic concentration of each 
surfactant throughout the pH range tested and the percentages of lysed erythrocytes were in 
agreement with the hemolytic activity results (Fig. 6). These observations indicate that 
hemoglobin is released into the PBS buffer after cell membrane lysis and is not related to 
increased cell membrane permeability or the opening of large pores sufficient to release 
hemoglobin molecules. 
 
SEM studies of rat erythrocyte morphology 
 
To better understand the interaction of cationic lysine-based surfactants with the lipid 
bilayer, we assessed morphological changes produced in rat erythrocytes by SEM after 
treatment with the surfactants at the sub-lytic concentration of 10 μg/ml at pH ranging from 
5.4 to 7.4. The results indicated that the surfactants interacted with the lipid bilayer and altered 
the normal biconcave morphology of the cells (Fig. 7). Control erythrocytes incubated in PBS 
solution at the pH values studied (7.4, 6.5 and 5.4) were also evaluated and found to be 
discoid or slightly echinocytic (Fig. 7a). This shape is considered normal in erythrocytes 
isolated in buffer and in the absence of albumin (Dubnicková et al. 2000; Rasia et al. 2007).  
Despite varying membrane lytic activity of MKM and MLM, erythrocytes underwent 
similar morphological alterations after treatment with these surfactants throughout the pH 
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range studied, indicating that morphological changes are not affected by the position of the 
cationic charge, unlike hemolytic activity, which is strongly affected. MKM and MLM 
changed the discoid shape of cells at pH 7.4 to stomatocytes (Fig. 7b and 7e, respectively), 
producing a cup-shaped form. This morphological change was induced when the compound 
was inserted into the inner monolayer of the membrane, expanding it relative to the outer 
layer. Our results are consistent with the bilayer hypothesis (Sheetz and Singer 1974), which 
proposes that cationic amphiphiles induce stomatocytes at physiological pH as a result of the 
electrostatic attraction between the positive polar head group of the molecule and the acidic 
phospholipids, the latter having negative charges under physiological conditions and 
localizing in the inner layer of the lipid bilayer. Furthermore, in mildly acidic media (pH 6.5), 
these two surfactants induced a spherostomatocyte-type deformation (Fig. 7c and 7f, 
respectively). The spherostomatocytes are formed from stomatocytes increasing the 
incorporation of compounds into the membrane, and are considered to be the previous stage 
before transformation to spherocytes. Finally, at pH 5.4, the cells displayed swollen forms 
(spherocytes), which can be assumed to be the last stage of the morphological change with 
maximum accumulation of the compound at the membrane before cell lysis (Fig. 7d and 7g, 
respectively). This increased accumulation at both pH 6.5 and 5.4 supports the significantly 
increased membrane lytic activity of MKM, since more interactions of the surfactants with the 
cell membrane could enhance hemolysis (Nogueira et al. 2011). In contrast, the higher 
incorporation of MLM into the erythrocyte membrane did not reflect increased hemolysis, 
suggesting that the accumulation of this compound in the lipid bilayer may play a protective 
role against hemolysis.  
In contrast, PKM (with a longer alkyl chain) interacted with the phospholipid bilayer 
in a slightly different way. At physiological pH, it induced a leptocyte-type deformation (Fig. 
7h), with the erythrocyte having a larger surface area than normal cells. This morphological 
change could be attributed to the higher incorporation of this surfactant into the lipid bilayer, 
thus giving an appearance of “excess” plasma membrane. A possible explanation is that the 
most common phospholipid in the bilayer is 16-18 carbons long, which could favor the 
incorporation of this compound (with 16 carbon atoms) into the membrane (Martínez et al. 
2007). This hypothesis of increased incorporation was not reflected in its hemolytic activity, 
possibly because this surfactant may rearrange the lipid bilayer and thus exert a protective 
effect at low concentrations. At pH 6.5, PKM also induced stomatocytes (Fig. 7i), but at an 
earlier stage than that observed with MKM and MLM. The less pronounced stomatocyte-type 
of deformation was consistent with the lower hemolytic activity of PKM at mildly acidic 
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conditions. At the pH range of late endosomes (pH 5.4), PKM caused spherocytes and some 
spherostomatocytes (Fig. 7j), which could also explain the significant rise in its membrane 
lytic activity (see discussion above).  
The same set of experiments was carried out across the pH range of 5.4 to 7.4 in the 
presence of PEG 10,000, an osmotic protectant against surfactant-induced hemolysis. We 
observed that PEG only partially protected against cell lysis (generally less than 50% 
protection), which is in agreement with the effects observed on the morphology of 
erythrocytes (data not shown). PEG did not recover the initial discocyte shape and only small 
changes were observed at pH 5.4 from spherocytes to stomatocytes for PKM and MKM, and 
at pH 7.4 from leptocytes to an early stage of stomatocytes for PKM. Therefore, no clear 
protective role of PEG was observed, corroborating the fact that osmotic cell swelling is not 
the only mechanism involved in the surfactant’s membrane-disruptive activity. In contrast to 
our results, some authors have reported that the presence of PEG induced significant changes 
in cell morphology (Zaragoza et al. 2010). 
The overall results showed that in addition to the physicochemical characteristics of 
the surfactants, differences in the transbilayer distribution and mobility are crucial for 
hemolytic potency. Of note, the increase in positive charges at the lipid bilayer due to the 
distribution of the surfactants might modify phospholipid packing, which determines the 
correct function of the membrane. This observation may also explain the changes in the 
normal biconcave shape of the red blood cells (Manrique-Moreno et al. 2010).  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
Conclusions 
 
 The membrane-disruptive activity of novel cationic lysine-based surfactants was 
assessed using erythrocytes as a model of an endosomal membrane. Although all the 
surfactants enhanced hemolysis with increasing concentrations, only the compounds with the 
positive charge on the α-amino group of lysine (MKM and PKM) showed pH-responsive 
hemolytic activity. Moreover, an increase in the alkyl chain length from 14 to 16 carbon atoms 
lowered the ability to disrupt cell membranes. Hence, the pH-dependent membrane-disruptive 
activity of these surfactants can be fine-tuned mainly by varying the position of the cationic 
charge and, to a lesser extent, by altering the length of the alkyl chain. The overall hemolysis 
results suggest that MKM and PKM might achieve maximum membrane lytic activity in the 
late endosomes, and the improved hemolytic kinetics demonstrate their ability to disrupt 
endosomal membranes before vesicular evolution from endosomes to lysosomes. The partial 
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decrease in the rate of hemolysis by PEG-10,000 implies that osmotic cell swelling is not the 
only mechanism involved in membrane lysis and that a more complex mechanism may 
operate. SEM studies on rat erythrocytes showed that the surfactants interacted with the 
phospholipid bilayer and induced shape changes, forming mainly stomatocytes at pH 7.4 and 
6.5, and spherocytes at pH 5.4. On the basis of our results, we conclude that the biocompatible 
surfactants MKM and PKM, but not MLM, have potential applications as a new class of 
bioactive excipients in drug delivery systems. These insights into the membrane-disruptive 
properties and mechanisms by which pH-sensitive surfactants facilitate the delivery of 
membrane-impermeant molecules into the cell cytoplasm may help in the design of specific 
endosome-destabilizing compounds. Furthermore, knowledge on the modulation of the 
physicochemical properties of novel surfactants may lead to the development of many more 
efficient amino acid-based drug carriers. Current studies are focusing on the development of 
lysine-based surfactant conjugates as potential biocompatible drug delivery systems for 
pharmaceutical applications. 
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Figure captions: 
 
Fig. 1 Molecular structures of the cationic lysine-based surfactants.  
Fig. 2 Dependence of rat erythrocyte hemolysis on surfactant concentration. (a) pH 7.4, (b) pH 
6.5 and (c) pH 5.4. Each point represents the mean of three independent experiments ± S.E.M. 
(error bars).  
Fig. 3 Surfactant-induced hemoglobin release from rat erythrocytes as a function of pH. 
Surfactants were added from concentrated solutions to give final concentrations of: (a) 50 
µg/ml MKM and PKM, 20 µg/ml MLM, or 5 µg/ml HTAB; and (b) 300 µg/ml MKM and 
PKM, 30 µg/ml MLM, or 10 µg/ml HTAB. Each point represents the mean of three 
independent experiments ± S.E.M. (error bars).  
Fig. 4 Kinetics of hemolytic activity of the lysine-based surfactants at  (a) pH 6.5 and (b) pH 
5.4. Surfactants were added at time zero from concentrated solutions to give final 
concentrations of: 25 µg/ml MKM, 50 µg/ml PKM, 20 µg/ml MLM and 5 µg/ml HTAB. Each 
point represents the mean of three independent experiments ± S.E.M. (error bars). 
Fig. 5 Effects of the osmotic protectant PEG-10,000 (10 kDa) and D-glucose (180 Da) on 
lysine-based surfactant-induced hemolysis of rat erythrocytes. Surfactants were added at the 
following range of final concentrations: (a) 500 µg/ml MKM, (b) 500 µg/ml PKM, and (c) 60 
µg/ml MLM. PBS alone (striped bars), PBS + D-glucose (blank bars) and PBS + PEG-10,000 
(black bars). The hemolysis results obtained in the presence of the osmolytes D-glucose and 
PEG-10,000 were compared to the control in PBS solution alone by ANOVA followed by 
Dunnett’s posthoc test. * P < 0.05, ** P < 0.01 and *** P < 0.005 denote significant differences. 
The data represent the mean of three independent experiments ± S.E.M. (error bars). 
Fig. 6 Comparison between the hemolysis (line) and the percentage of lysed rat erythrocytes 
(columns) caused by the cationic lysine-based surfactants at the pH range tested. Surfactants 
were added at the following range of final concentrations: (a) 500 µg/ml MKM, (b) 500 µg/ml 
PKM, and (c) 60 µg/ml MLM. The data represent the mean of three independent experiments 
± S.E.M. (error bars). 
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Fig. 7 Effect of the cationic lysine-based surfactants on rat erythrocyte morphology. SEM 
images of (a) control in PBS pH 7.4, and after incubation with the surfactants: MKM at (b) pH 
7.4, (c) pH 6.5 and (d) pH 5.4; MLM at (e) pH 7.4, (f) pH 6.5 and (g) pH 5.4; and PKM at (h) 
pH 7.4, (i) pH 6.5 and (j) pH 5.4. The erythrocytes were incubated for 10 minutes at a 
concentration of 10 µg/ml of each surfactant. Scale bars correspond to 5µm. 
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Table 1 Physicochemical properties and analytical data for the cationic lysine-based 
surfactants. 
Surfactant 
MW
a
 
(g/mol) 
CMC
b 
(μg/ml) 
pKa
b 
Number 
of alkyl 
chains 
Length 
of alkyl 
chain 
Elemental analysis (%) (% calculated)
e 
C H N 
MKM 406.66 650
c 5.3
c 
1 C14 61.77 (62.02) 10.78 (10.56) 6.73 (6.88) 
PKM 434.66 260
c 4.5
c 
1 C16 63.61 (63.49) 11.20 (10.81) 6.37 (6.44) 
MLM 406.66 765
d 8.1
d 
1 C14 61.76 (62.02) 10.42 (10.56)  6.62 (6.88) 
a Molecular weight 
b Determined in water 
c 
Colomer et al. (2011b) 
d Determined as described in “Hemolysis assay” and “pH-dependent hemolysis” sections 
e Pérez et al. (2009) 
Table
Table 2 HC50 values of the surfactants in the pH range studied. 
 HC50 (µg/ml)  (mean
a
 ± S.E.M.) 
Surfactants  pH 7.4 pH 6.5 pH 5.4 
MKM  340.86 ± 14.03 56.45 ± 12.10
d 
< 50
b 
PKM  356.27 ± 13.68 199.84 ± 24.54
d 
< 50
b 
MLM  38.88 ± 3.51 98.58
c
 ± 1.53
e 
75.51
c
 ± 20.73
 
HTAB  11.61 ± 0.88 11.48 ± 1.57 11.49 ± 1.79 
a 
Mean ± S.E.M. of three experiments 
b
The lowest concentration tested displayed more than 50% hemolysis. 
c
 Estimated value (out of experimental curve range) 
d 
Significantly different from the pH 7.4 condition (Student t test, P < 0.05) 
e 
Significantly different from the pH 7.4 condition (ANOVA followed by Bonferroni`s post-hoc test, P < 0.05) 
 
 
Table
